Abstract:
The present invention relates to protein constructs that comprise one or more peptides, proteins, factors, compounds or other components as further described herein that are linked to and/or are linked to each other via a helical polymeric backbone. The constructs of the invention are suitable for administration to a human or animal body and can be used for pharmaceutical purposes, for example for immunotherapy such as for treating cancer and for other immunological applications, as well as for other therapeutic, prophylactic and/or diagnostic purposes.
Abstract:
The current invention relates to a method for identifying a subject at risk of developing an idiopathic inflammatory myopathy and/or diagnosing a subject suffering from an idiopathic inflammatory myopathy, preferably wherein said idiopathic inflammatory myopathy is Inclusion Body Myositis. The invention provides methods in diagnosis, use of specific antigens, and kits for use in studying the presence or absence of (auto)antibodies in samples derived from subjects.
Abstract:
The present invention relates to protein constructs that comprise one or more peptides, proteins, factors, compounds or other components as further described herein that are linked to and/or are linked to each other via a helical polymeric backbone. The constructs of the invention are suitable for administration to a human or animal body and can be used for pharmaceutical purposes, for example for immunotherapy such as for treating cancer and for other immunological applications, as well as for other therapeutic, prophylactic and/or diagnostic purposes.
Abstract:
Disclosed are biocompatible cryogels comprising one or more biomolecules, such as antibodies, protein complexes, enzymes, DNA and polysaccharides. Also disclosed are methods of making the cryogels.
Abstract:
The invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of an COCH associated condition.
Abstract:
Oropharyngeal airway device having a singular body (2) of a first material. The singular body (2) has an elongate shape along a substantially longitudinal axis (3) and has a uniform cross section perpendicular to the substantially longitudinal axis (3). The substantially uniform cross section has at least three stub portions (4) extending radially from the substantially longitudinal axis (3) and defining open airway sections of the oropharyngeal airway device. The at least three stub portions (4) are at an equal angle to each other in the substantially uniform cross section.
Abstract:
A device (2) for providing circulatory assistance is provided and comprises a balloon (4) comprising a membrane defining a cavity having an internal volume (Vc), wherein the balloon comprises a proximal portion (4a) comprising a proximal end and a distal portion (4b) comprising a distal end. The device (2) further comprises a first catheter, affixed to the distal end of the balloon (4) at a first fixation point (P1) and a second catheter (8), affixed to the proximal end of the balloon at a second fixation point (P2). The second catheter (8) is configured for axial movement with respect to the first catheter or guide wire (6) between a first position in which the first and second fixation points (P1, P2) are spaced apart from each other in the longitudinal direction by a first distance (Dx), which is variable to bring about inversion of the balloon.
Abstract:
A breath sampler (100) for collecting a breath sample from a patient is disclosed. The breath sampler comprises a non-rebreather part (110) comprising a sample inlet (130), a one-way outlet valve (160) downstream of the sample inlet (130), and an air inlet (140). The one-way outlet valve (160) and the sample inlet (130) define a first portion of an internal breath flow pathway therebetween. The air inlet (140) is arranged to be closed by a one-way inlet valve arranged to allow air to enter the nonrebreather part (110). The breath sampler also comprises a sample delivery part (120) in fluid communication with the non-rebreather part (110) at an upstream end via the one-way outlet valve (160). The sample delivery part (120) defines a second portion of the internal breath flow pathway, and comprises an air diverter (170), a sample outlet (190), a return inlet (195) and a sample collection chamber connector (150). The air diverter (170) is arranged to divide the sample delivery part (120) into an upstream portion upstream of the air diverter (170) and a downstream portion downstream of the air diverter and is configured to divert the breath sample into a sample collection chamber (200) comprising a liquid capture interface. The breath sampler further comprises the sample collection chamber (200) coupled to the sample collection chamber connector, the sample collection chamber comprising a liquid capture interface.
Abstract:
The present invention relates to a flexible polyurethane foam sheet comprising a pharmacologically active agent, a process of preparing such a sheet, and to the use of such a sheet for treatment and/or prophylaxis of the human or animal body.